Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA recalls thousands of antidepressant bottles
FDA Duloxetine recall flags 7,100+ bottles of generic Cymbalta antidepressants
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine: Here’s Why
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals in the medication.
FDA eyes McDonald's supplier's onions
FDA eyes McDonald's supplier's onions as source of E. Coli outbreak
The FDA said Thursday that it's investigating whether McDonald’s supplier Taylor Farms is the possible source of the E. coli outbreak linked to Quarter Pounders hamburgers.
What to know about E. coli causes, symptoms amid McDonald’s-linked outbreak
One person died and 10 were hospitalized in an E. coli outbreak in 10 states, which health officials linked to the McDonald’s burgers.
FDA identifies possible sources of McDonald's E. coli outbreak
The FDA is looking into two possibilities as the source of an E. coli outbreak linked to McDonald's Quarter Pounder burgers. CBS News Colorado reporter Karen Morfitt has the latest.
20h
on MSN
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Managed Healthcare Executive
4h
FDA Approves Stelara Biosimilar Selardsi for Additional Formulation
This week’s approval expands Seldardsi indications to treat adults with Crohn’s disease and ulcerative colitis.
BioSpace
2h
GLP-1 Prescriptions for Type 1 Diabetes Spike Despite Lack of FDA Approval: Study
While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...
ENDPOINTS NEWS
4h
Novo Nordisk petitions FDA to stop semaglutide compounding over safety risks
Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...
Richmond
3h
New FDA rules require plain language for mammograms
In September, the U.S. Food and Drug Administration released new rules that require a summary be sent directly to patients ...
23h
on MSN
FDA and CBP Seize $76 Million in Illegal Vapes From China
Roughly 3 million units were confiscated in the operation as part of a federal crackdown on illegal e-cigarettes.
Acsh.org
15h
The Anniversary of FDA's Landmark Approval of Genetically Engineered Human Insulin: A Cautionary Tale
Often, they do not. Next Tuesday, October 29 th, marks the 42nd anniversary of one of biotechnology's most significant ...
18h
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copy-cats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
recall
Food and Drug Administration
Cymbalta
Duloxetine
Pfizer
Feedback